Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders, inhibitors |
Mechanism WEE1 degraders(Serine/threonine-protein kinase WEE1 degraders), WEE1 inhibitors(Serine/threonine-protein kinase WEE1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC53H65N13O11 |
InChIKeyOXMQPPFNQZKQHV-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United Kingdom | 26 Feb 2022 |